Description
Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids offers a revolutionary investigation of the complicated relationships between cancer metabolism and three crucial factors: the gut microbiota, reactive oxygen species (ROS), and the dysregulation of the short chain fatty acid (SCF) complex. This book adopts a thorough and interdisciplinary approach to untangle the intricate interactions between these components, providing fresh perspectives that fundamentally alters the understanding of cancer biology and therapy. In 14 chapters.Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids provides a thorough investigation of the metabolic changes that occur inside cancer cells, illuminating how these changes promote tumour survival and progression, from introduction to future aspects. Researchers in cancer research, and gut microbiology will find this an essential reference.- Creates new opportunities for focused therapies and patient-specific therapy plans by exploring the roles of the gut microbiota, ROS, and SCF dysregulation in cancer metabolism- Discusses in-vitro, ex-vivo, and animal models used to examine the effects of probiotics and their metabolites in cancer care- Focuses on cutting-edge research on probiotics and their byproducts treatments in oncogene downregulation, autophagy induction, kinase inhibition, tumour suppressor reactivation, and metastasis prevention
Table of Contents
1. Introduction to Gut Microbiota in Cancer Metabolism2. Cancer Metabolic Rewiring of Reactive Oxygen Species3. Emerging strategies in Cancer metabolism: Role of Gut microbiota, reactive oxygen species, and short chain fatty acids4. Exploring the Link Between Gut Microbiome and Cancer: Metabolic Implications and Therapeutic Avenue5. Oxidative Stress and Cancer Metabolism: From Pathogenesis to Therapeutic Opportunities6. Targeting ROS Signaling Pathways for Cancer Metabolic Reprogramming7. SCF Complex: Master Regulator of Metabolic Adaptations in Cancer Cells8. Manipulating gut microbial metabolites for cancer therapy: A Metabolism-centric approach9. Metabolic Crossroads: Integrating ROS, SCF and Gut Microbiota in Cancer10. Therapeutic Advances: Modulating Gut Microbiota, ROS, and SCF Pathways in Cancer Treatment11. Precision Medicine in Cancer Metabolism: Personalized Approaches Exploiting Metabolic Vulnerabilities12. Novel Biomarkers and Therapeutic Targets: Harnessing Metabolic Insights for Improved Cancer Management13. Future aspects: Novel Strategies in Cancer Metabolism Research and Clinical Interventions14. Novel approach in Bridging the Gap between Cancer Biology and Metabolism15. Implementing Gut Microbiota, ROS, and SCF Modulation in Cancer Care: Research into Practice
